Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Spatafora

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Allergy|October 27, 2010
A 15-year-old boy with anterior chest pain, progressive dyspnea, and subcutaneous emphysema of the neckNicola Scichilone, Maria Buttacavoli, Gaetana Camarda, et al.
Journal of Asthma and Allergy|February 5, 2013
Lung penetration and patient adherence considerations in the management of asthma: role of extra-fine formulationsNicola Scichilone, Mario Spatafora, Salvatore Battaglia, et al.
The European Respiratory Journal|March 19, 2016
Asthmatics with high levels of serum surfactant protein D have more severe diseaseAlida Benfante, Salvatore Battaglia, Stefania Principe, et al.
Sleep|May 17, 2003
Sleep disorders in the elderly with and without chronic airflow obstruction: the SARA studyVincenzo Bellia, Filippo Catalano, Nicola Scichilone, et al.
Immunology|October 17, 2013
Gemcitabine sensitizes lung cancer cells to Fas/FasL system-mediated killingLiboria Siena, Elisabetta Pace, Maria Ferraro, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2010
Altered CD94/NKG2A and perforin expression reduce the cytotoxic activity in malignant pleural effusionsElisabetta Pace, Caterina Di Sano, Maria Ferraro, et al.
American Journal of Respiratory and Critical Care Medicine|February 8, 2003
Biologically active intercellular adhesion molecule-1 is shed as dimers by a regulated mechanism in the inflamed pleural spaceMario Melis, Elisabetta Pace, Liboria Siena, et al.
Multidisciplinary Respiratory Medicine|April 28, 2021
Comments on "Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations" by D'Amato <i>et al.</i>Girolamo Adiletta, Stefano Baglioni, Germano Bettoncelli, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2012
Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancerMassimo Di Maio, Natasha B Leighl, Ciro Gallo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly studyPaolo Maione, Francesco Perrone, Ciro Gallo, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Allergy|October 27, 2010
A 15-year-old boy with anterior chest pain, progressive dyspnea, and subcutaneous emphysema of the neckNicola Scichilone, Maria Buttacavoli, Gaetana Camarda, et al.
Journal of Asthma and Allergy|February 5, 2013
Lung penetration and patient adherence considerations in the management of asthma: role of extra-fine formulationsNicola Scichilone, Mario Spatafora, Salvatore Battaglia, et al.
The European Respiratory Journal|March 19, 2016
Asthmatics with high levels of serum surfactant protein D have more severe diseaseAlida Benfante, Salvatore Battaglia, Stefania Principe, et al.
Sleep|May 17, 2003
Sleep disorders in the elderly with and without chronic airflow obstruction: the SARA studyVincenzo Bellia, Filippo Catalano, Nicola Scichilone, et al.
Immunology|October 17, 2013
Gemcitabine sensitizes lung cancer cells to Fas/FasL system-mediated killingLiboria Siena, Elisabetta Pace, Maria Ferraro, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2010
Altered CD94/NKG2A and perforin expression reduce the cytotoxic activity in malignant pleural effusionsElisabetta Pace, Caterina Di Sano, Maria Ferraro, et al.
American Journal of Respiratory and Critical Care Medicine|February 8, 2003
Biologically active intercellular adhesion molecule-1 is shed as dimers by a regulated mechanism in the inflamed pleural spaceMario Melis, Elisabetta Pace, Liboria Siena, et al.
Multidisciplinary Respiratory Medicine|April 28, 2021
Comments on "Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations" by D'Amato <i>et al.</i>Girolamo Adiletta, Stefano Baglioni, Germano Bettoncelli, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2012
Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancerMassimo Di Maio, Natasha B Leighl, Ciro Gallo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly studyPaolo Maione, Francesco Perrone, Ciro Gallo, et al.
Pageof 3